We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

This week on “The Top Line,” we break down the biggest stories out of JPM, from J&J’s blockbuster acquisition of ...

A major conference that took place earlier this month is set to return to San Francisco next year, according to SF Mayor Daniel Lurie’s office. The J.P. Morgan ...

Health care executives continue to reimagine and reshape their organizations. Their ideas were developing in real time during ...

While some analysts expect the 2025 IPO market to be relatively cool in the near-term, others anticipate more bids than in ...

The desire of digital health companies to scale through mergers and acquisitions or partnerships was one of the most ...

Kyverna Therapeutics, Inc., a leading biotechnology company focusing on autoimmune diseases, revealed its strategic priorities for the year 2025 and anticipated milestones in a recent press release on ...

Top Execs from Agilent, Waters, and Bruker Take the Stage at J.P. Morgan Healthcare Conference. Aaron Acevedo. The 43 rd Annual Healthcare J.P. Morgan Healthcare Conference kicked ...

What are biopharma VCs looking to invest in this year? Autoimmune disorders, osteoporosis, and cardiovascular disease are ...

Biopharma executives make their predictions for the year ahead, from a bold forecast for the return of the megadeal to a plea ...

This year’s JP Morgan struck a different tone than previous years—a very pleasant one, despite higher security anxieties ...